Position in TARS
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$49,458,753
-$2,627,409 QoQ
Shares Held
785,808
+5.8% QoQ
Ownership
1.79%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#16
of 256 holders
Holding Since
Dec 2020
22 quarters on record
Voting authority
Sole 0%
Shared 93%
None 7%
Common Shares in TARS Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Invesco Ltd. holds $14,420,023,301 across 296 Biotechnology names. TARS ranks #31 (0.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
8,043,052 | $3,995,225,212 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
3,940,665 | $2,457,162,245 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
3,754,318 | $1,130,162,341 | |
| 4 | INCY |
Incyte Corp
|
4,080,461 | $462,561,050 | |
| 5 | ARGX |
Argenx SE
|
443,990 | $411,920,598 | |
| 6 | AXSM |
Axsome Therapeutics, Inc.
|
1,671,684 | $409,178,086 | |
| 7 | MRNA |
Moderna, Inc.
|
5,780,299 | $404,794,337 | |
| 8 | LGND |
Ligand Pharmaceuticals Inc
|
1,201,644 | $379,827,645 |
All Filings in TARS
Export CSV
22 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $49,458,753 | 785,808 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $52,086,162 | 742,497 | Shares | Defined | 2026-05-12 | |
| 2025-12-31 | $82,891,789 | 1,012,357 | Shares | Defined | 2026-02-19 | |
| 2025-09-30 | $55,686,264 | 937,006 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $37,613,573 | 928,501 | Shares | Defined | 2025-08-13 | |
| 2025-03-31 | $42,458,484 | 826,523 | Shares | Defined | 2025-05-12 | |
| 2024-12-31 | $51,611,206 | 932,115 | Shares | Defined | 2025-02-13 | |
| 2024-09-30 | $22,434,167 | 682,097 | Shares | Defined | 2024-11-12 | |
| 2024-06-30 | $10,642,680 | 391,563 | Shares | Defined | 2024-08-13 | |
| 2024-03-31 | $8,126,731 | 223,569 | Shares | Defined | 2024-05-14 | |
| 2023-12-31 | $1,981,928 | 97,873 | Shares | Defined | 2024-02-13 | |
| 2023-06-30 | $754,764 | 41,769 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $769,006 | 61,178 | Shares | Defined | 2023-05-12 | |
| 2022-12-31 | $831,718 | 56,734 | Shares | Defined | 2023-02-13 | |
| 2022-09-30 | $696,150 | 40,663 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $622,207 | 42,617 | Shares | Defined | 2022-08-15 | |
| 2022-03-31 | $470,657 | 27,982 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $537,839 | 23,904 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $616,631 | 28,614 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $881,803 | 30,428 | Shares | Defined | 2021-08-17 | |
| 2021-03-31 | $943,016 | 29,259 | Shares | Defined | 2021-05-17 | |
| 2020-12-31 | $800,437 | 19,367 | Shares | Defined | 2021-02-16 | |
| No filing history on record for this holder in this stock. | ||||||